Social media ambassadors and collaboration with OncoAlert: a European Network of Young Gynae Oncologists study of comparative Twitter analysis of #ESGO2021 and #ESGO2022.


Journal

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
ISSN: 1525-1438
Titre abrégé: Int J Gynecol Cancer
Pays: England
ID NLM: 9111626

Informations de publication

Date de publication:
05 06 2023
Historique:
medline: 7 6 2023
pubmed: 3 5 2023
entrez: 2 5 2023
Statut: epublish

Résumé

The primary objective was to reveal the impact of social media ambassadors and the collaboration between the European Society of Gynaecological Oncology (ESGO) and the OncoAlert Network on Twitter during the ESGO 2022 Congress by comparing it with the ESGO 2021 Congress. We also aimed to share our experience on how to organize a social media ambassador program and evaluate the potential benefits for the society and the ambassadors. We defined the impact as promoting the congress, sharing the knowledge, change in follower count, and change in tweet, retweet, and reply counts. We used the Academic Track Twitter Application Programming Interface to retrieve data from ESGO 2021 and ESGO 2022. We used the keywords of ESGO2021 and ESGO2022 to retrieve data for each of the conferences. The time range in our study captured interactions from before, during, and after conferences. We collected the ambassadors', ESGO's, and the European Network of Young Gynae Oncologists' (ENYGO's) follower data on Twitter from November 2021 to November 2022 for comparative analysis. There was a 7.23-fold increase in the use of the official congress hashtag in 2022 compared with 2021. Compared with #ESGO2021 data, the main interventions of the Social Media Ambassadors and OncoAlert partnership determined 7.79-, 17.36-, 5.50-, 10.58-, and 8.50-fold increases with #ESGO2022 data in the mentions, mentions in retweet, tweet, retweet, and replies, respectively. Similarly, all other most commonly used hashtags in the top 10 list indicated a range from 2.56- to 7.00-fold increase. Compared to the ESGO 2021 congress month, ESGO and the majority (83.3%, n=5) of ambassadors gained more followers during ESGO 2022 congress month. An official social media ambassadors program and collaboration with influential accounts in the field of interest are beneficial for congress-related engagement on a social media platform (Twitter). Individuals participating in the program can also benefit from gaining higher visibility among specific audience.

Identifiants

pubmed: 37130625
pii: ijgc-2023-004371
doi: 10.1136/ijgc-2023-004371
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

964-970

Informations de copyright

© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Esra Bilir (E)

Department of Gynecologic Oncology, Koc University School of Medicine, Istanbul, Turkey.
Department of Global Health, Koc University Graduate School of Health Sciences, Istanbul, Turkey.
Department of Obstetrics and Gynaecology, Die Klinik in Preetz, Preetz, Germany.

Wasim Ahmed (W)

Stirling University Management School, Stirling, UK.

Joanna Kacperczyk-Bartnik (J)

II Department of Obstetrics and Gynaecology, Medical University of Warsaw, Warsaw, Poland asiakacperczyk@gmail.com.

Sara Nasser (S)

Department of Gynecology and Tumor Surgery, Charite Comprehensive Cancer Center, Berlin, Germany.

Pernille Bjerre Trent (P)

Department of Gynecologic Oncology, Division of Cancer Medicine, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo Faculty of Medicine, Oslo, Norway.

Felix Boria (F)

Gynecologic Unit, Clinica Universidad de Navarra, Madrid, Spain.

Irina Tsibulak (I)

Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.

Enrique Chacon (E)

Gynecologic Oncology Unit, Universidad de Navarra, Pamplona, Spain.

Fabio Martinelli (F)

Department of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Aleksandra Natalia Strojna (AN)

Department of Gynecology and Gynecologic Oncology, Evangelische Kliniken Essen Mitte, Essen, Germany.

Gilberto Morgan (G)

Department of Medical Oncology, Skåne University Hospital, Lund, Sweden.
OncoAlert Network.

Nicolò Bizzarri (N)

UOC Ginecologia Oncologica, Dipartimento per la Salute della Donna e del Bambino e della Salute Pubblica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Ane Gerda Eriksson (AG)

Department of Gynecologic Oncology, Division of Cancer Medicine, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway.

Charalampos Theofanakis (C)

Division of Gynaecological Oncology, 1st Department of Obstetrics & Gynaecology, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH